TNF-α levels were also found to be positively correlated with other markers of insulin resistance [19]; nonetheless, acute treatment with TNF-α inhibitor in obese subjects with type 2 diabetes reduced other systemic inflammatory markers without reducing insulin resistance [20], fueling lingering uncertainty about the biological relevance of this pathway in human insulin resistant states. Here, TNF is linked to type 2 diabetes mellitus.